Back
Lyell Immunopharma Stock Price Chart
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
25
LYEL
Lyell Immunopharma
Last Price:
1.57
Seasonality Move:
-32.08%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing buying pressure, which is a positive indicator for future bullish movement.
Lyell Immunopharma Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.28 | Buy |
| 20-day SMA: | 1.35 | Buy |
| 50-day SMA: | 1.46 | Buy |
| 200-day SMA: | 2.01 | Sell |
| 8-day EMA: | 1.35 | Buy |
| 20-day EMA: | 1.34 | Buy |
| 50-day EMA: | 1.49 | Buy |
| 200-day EMA: | 1.96 | Sell |
Lyell Immunopharma Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 60.93 | Buy |
| Chaikin Money Flow: | 446991 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.21 - 1.49) | Buy |
| Bollinger Bands (100): | (1.34 - 2.4) | Sell |
Lyell Immunopharma Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Lyell Immunopharma Stock
Is Lyell Immunopharma Stock a Buy?
- Lyell Immunopharma share price is 1.56 while LYEL 8-day simple moving average is 1.28, which is a Buy signal.
- The stock price of LYEL is 1.56 while Lyell Immunopharma 20-day SMA is 1.35, which makes it a Buy.
- Lyell Immunopharma 50-day simple moving average is 1.46 while LYEL share price is 1.56, making it a Buy technically.
- LYEL stock price is 1.56 and Lyell Immunopharma 200-day simple moving average is 2.01, creating a Sell signal.
LYEL Technical Analysis vs Fundamental Analysis
Sell
25
Lyell Immunopharma (LYEL)
is a Sell
Is Lyell Immunopharma a Buy or a Sell?
-
Lyell Immunopharma stock is rated a Sell
The current Lyell Immunopharma [LYEL] share price is $1.56. The Score for LYEL is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Lyell Immunopharma Stock Info
Market Cap:
399.36M
Price in USD:
1.56
Share Volume:
744.99K
Lyell Immunopharma 52-Week Range
52-Week High:
3.26
52-Week Low:
1.09
Sell
25
Lyell Immunopharma (LYEL)
is a Sell
Lyell Immunopharma Share Price Forecast
-
What is the Lyell Immunopharma stock price today?
The Lyell Immunopharma stock price is 1.56 USD today. -
Will LYEL stock go up or go down?
Lyell Immunopharma> share price is forecast to RISE/FALL based on technical indicators -
Is Lyell Immunopharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lyell Immunopharma is overvalued.
Is Lyell Immunopharma Stock a Buy?
- Lyell Immunopharma share price is 1.56 while LYEL 8-day exponential moving average is 1.35, which is a Buy signal.
- The stock price of LYEL is 1.56 while Lyell Immunopharma 20-day EMA is 1.34, which makes it a Buy.
- Lyell Immunopharma 50-day exponential moving average is 1.49 while LYEL share price is 1.56, making it a Buy technically.
- LYEL stock price is 1.56 and Lyell Immunopharma 200-day simple moving average is 1.96, creating a Sell signal.
Fundamental Analysis of Lyell Immunopharma
Is Lyell Immunopharma a good investment?
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.04 per share.
Technical Analysis of Lyell Immunopharma
Should I short Lyell Immunopharma stock?
- LYEL Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Lyell Immunopharma is a Sell
- Lyell Immunopharma Relative Strength Index (RSI) is 60.93, which suggest Lyell Immunopharma is overbought
- The Bollinger Bands (25) for Lyell Immunopharma is (1.21 - 1.49), which suggest Lyell Immunopharma is a Sell
- The Bollinger Bands (100) for Lyell Immunopharma is (1.34 - 2.4), which suggest Lyell Immunopharma is a Sell
* Lyell Immunopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.